DRUGS & DIAGNOSTICS FOR TROPICAL DISEASE

EIN: 274482027 501(c)(3) Medical Research

SAN DIEGO, CA

Total Revenue
$1,331,567
Total Expenses
$835,433
Total Assets
$733,464
Net Assets
$723,752
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2010
Legal Domicile
CA
Principal Officer
w
Phone
8584051277
Tax Period
2023-01-01 to 2023-12-31

DRUGS & DIAGNOSTICS FOR TROPICAL DISEASE, founded in 2010, is a community nonprofit in the Medical Research sector that reported $1.3M in total revenue in fiscal year 2023. Revenue surged 128% from the prior year, signaling strong growth momentum. The organization ran a surplus of $496K, a strong 37% operating margin.

Mission

Deliver new drugs and new diagnostics for diseases that affect predominantly economically vulnerable populations.

Program Service Accomplishments

Program 1
Expenses: $613,632

Research work for diagnostics to detect Buruli ulcer, river blindness, and other neglected tropical diseases. Research serves about 18 million people (river blindness), 40 million people (lymphatic...

Read more

Research work for diagnostics to detect Buruli ulcer, river blindness, and other neglected tropical diseases. Research serves about 18 million people (river blindness), 40 million people (lymphatic filariasis), and 10 million people (paragonimus).

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,310,080
Program Service Revenue $0
Investment Income $0
Other Revenue $21,487
TOTAL REVENUE $1,331,567

Expense Breakdown

Grants Paid $0
Salaries & Benefits $240,582
Fundraising Expenses $119,345
Program Expenses $613,632
Other Expenses $594,851
TOTAL EXPENSES $835,433

Year-over-Year Comparison

2023 2022 Change
Revenue $1,331,567 $584,559 +1.3%
Expenses $835,433 $746,872 +0.1%
Net Income $496,134 $-162,313 -4.1%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
7
Independent Members
6
Employees
5
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
3
$44,055
Total Directors
6
$44,055
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
MARCO A BIAMONTE President & CEO 20.00
Officer Director
$39,660 $4,395 $44,055
VISH GAITONDE Treasurer 1.00
Officer Director
$0 $0 $0
BEVERLY COYNE Secretary 1.00
Officer Director
$0 $0 $0
JOSH SALISBURY Director 1.00
Director
$0 $0 $0
MATTHEW WAXMAN Director 1.00
Director
$0 $0 $0
THOMAS BLACKSHAW Director 1.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 No data No data No data No data
2024 No data No data No data No data
2023 $1,331,567 $835,433 $733,464 $496,134
2022 $584,559 $746,872 $243,205 $-162,313
2021 $618,124 $738,573 $391,460 $-120,449
2020 $779,385 $674,983 $518,051 $104,402
2019 $725,745 $303,679 $407,541 $422,066
2018 $98,011 $256,402 $145,651 $-158,391
Explore More Nonprofits
→Top 100 Nonprofits in California →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare DRUGS & DIAGNOSTICS FOR TROPICAL DISEASE with other nonprofits in California and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.